A new report by one of the UK’s top four accounting firms has concluded that the impact of community pharmacy in Northern Ireland over the last ten years and throughout COVID has been transformative in supporting patients and the health service but increased investment in the sector is required to enable community pharmacy to continue its important contribution to primary care.
The new report by KPMG highlights the resilience of the sector in meeting a steep rise in demand during COVID-19 through the provision of enhanced frontline services to communities during that time.
The report also shows a minimum 16% increase in the basic annual cost of providing commissioned services from £126million in 2011/12 to £146million in 2020/21, as well as an increase in workload with dispensing activity and other pharmacy services up by 49%.
The report comes 16 months after community pharmacists unanimously voted to take industrial action following years of funding shortfalls by the Department of Health. This planned action was paused when the pandemic struck in March 2020 and pharmacies took the decision to remain open and provide an uninterrupted service to patients.
In response to the latest report, Community Pharmacy NI is calling on the Department of Health to consider the report’s findings as attention turns to transformation of the health service, and within that, the changes needed in primary care services.
Chief Executive of Community Pharmacy NI, Gerard Greene said:
“This report shows the reality of the community pharmacy response during COVID and the costings for community pharmacy services in Northern Ireland. Since 2011, we have seen rising costs and an overall increase in service provision so on-going and enhanced investment in the sector is required.
“With continued pressures on the health service, community pharmacies have, and will continue to see, an increased reliance on the service by patients with an associated increase in costs, dispensing and services over the next ten years. Funding therefore must match this rise in demand to ensure the correct provision of care is afforded to patients.
“In early 2020, the community pharmacy network was in crisis. Our pharmacists had reached breaking point and voted in favour of industrial action. When the pandemic arrived, we put aside these long-standing issues to support the patients reliant on our services at a time when many services closed.
“The Health Minister recognised the pressure and allocated the funds required to meet pandemic demand in July 2020. However, this funding only addressed issues for one year and meant that community pharmacy contractors could remain open to support patients at a time of national crisis. This level of funding needs to be recurrent, matched to the cost of providing the service and a long-term solution is now needed.
“As we move out of the pandemic, and talk turns to transformation, it is imperative that community pharmacy is part of the discussion around planning for primary care. We have proven time and time again that we are a vital component part of the health service. Investment and forward planning are now required for our services to be elevated so we can continue to support our communities.”
Peter Rice, UCA Chairman and Vice Chair of Community Pharmacy NI, said:
“The community pharmacy network has been under significant pressure particularly through the pandemic but the sector stood up and this report shows the value of pharmacy to the NHS. There is a real opportunity now to move things forward. We are keen to see community pharmacy play its part, and with the necessary investment to ensure the sector can continue to contribute to the health service in line with the Minister’s stated objectives.”